Claybrook Capital, LLC Pfizer Inc Transaction History
Claybrook Capital, LLC
- $172 Million
- Q3 2023
A detailed history of Claybrook Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Claybrook Capital, LLC holds 10,705 shares of PFE stock, worth $276,510. This represents 0.21% of its overall portfolio holdings.
Number of Shares
10,705
Previous 10,500
1.95%
Holding current value
$276,510
Previous $385,000
7.79%
% of portfolio
0.21%
Previous 0.21%
Shares
14 transactions
Others Institutions Holding PFE
# of Institutions
3,258Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13.3 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$11 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.5 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.23 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.36 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $145B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...